Genetics Articles Retracted at Higher Rate than Other Disciplines

A study estimates that 0.15 percent of genetics articles are retracted, most commonly for duplication and plagiarism.

Written byChia-Yi Hou
| 2 min read
retraction genetics studies articles papers medical rate plagiarism duplication fabrication

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM,
DOMIN_DOMIN

Genetics articles are retracted at an estimated rate of 0.15 percent, which is about four times higher than for all disciplines (this includes genetics) listed in the Retraction Watch database, researchers reported in the Journal of Medical Genetics on July 25. They find that duplication is the most common reason for retracting genetics papers.

The authors looked at 1,582 retracted genetics articles that were published between 1970 and 2018 and catalogued in the Retraction Watch database and split them into medical genetics (44 percent) and non-medical genetics (56 percent). Twenty-eight percent of the non-medical genetics articles contained fabricated or falsified data and 26.3 percent involved duplication. In medical genetics articles, duplication (21.6 percent) was more common than fabricated or falsified data (18.5 percent). The other retraction reasons included plagiarism, unreliable information, and authorship issues, which combined account for about one-third of the retractions for both categories.

To ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies